Wednesday, July 22, 2026

How EU Mediation in 2+1 North-South Political Dialogue Could Transform Korean Peninsula Peace

Unification Minister Chung proposes EU-mediated inter-Korean dialogue to foster peace, citing Europe's historical success in conflict resolution.

Lunit Scope: How AI Biomarkers Are Revolutionizing Cancer Treatment at AACR 2026

Lunit to present six AI biomarker studies at AACR 2026, showcasing advancements in cancer treatment and AI technology.

Pharmaresearch Acquires CG USA to Strengthen Localization Strategy for Rejuran Cosmetics in the U.S.

Pharmaresearch acquires CG USA to enhance supply chain and meet growing demand for Rejuran Cosmetics in North America.

Tag: ABL209

ABL209: The Promising Dual Antibody ADC Revolutionizing Cancer Treatment in 2026

ABL Bio's ABL209 shows promising anti-cancer effects with broad safety in preclinical studies, advancing to Phase 1 trials in the U.S.

Top News

- Our Sponsors Ad -

Follow us